(Q35810060)

10 August 2017

1 reference

title

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists (English)

1 reference

10 August 2017

0 references

Joseph I Friedman

1

1 reference

10 August 2017

publication date

19 February 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

174

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

45-53

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-1794-x

10 August 2017

exact match

0 references

cites work

Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeys

1 reference

12 December 2020

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

1 reference

12 December 2020

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

1 reference

12 December 2020

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

1 reference

12 December 2020

The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

1 reference

12 December 2020

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study

1 reference

12 December 2020

An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia

1 reference

12 December 2020

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

1 reference

12 December 2020

Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss

1 reference

12 December 2020

Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

1 reference

12 December 2020

Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors

1 reference

12 December 2020

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

1 reference

12 December 2020

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

12 December 2020

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

12 December 2020

Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man.

1 reference

12 December 2020

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

1 reference

12 December 2020

The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.

1 reference

12 December 2020

Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization

1 reference

12 December 2020

Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry

1 reference

12 December 2020

The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicit and contextual cues and spatial learning in the water maze.

1 reference

12 December 2020

Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice

1 reference

12 December 2020

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

1 reference

12 December 2020

The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

12 December 2020

Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.

1 reference

12 December 2020

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

1 reference

12 December 2020

Postmortem studies in schizophrenia.

1 reference

12 December 2020

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

1 reference

12 December 2020

Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine.

1 reference

12 December 2020

Recall memory deficit in schizophrenia. A possible manifestation of prefrontal dysfunction.

1 reference

12 December 2020

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

1 reference

12 December 2020

Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

1 reference

12 December 2020

Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.

1 reference

12 December 2020

Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task

1 reference

12 December 2020

Cholinergic gating of response to auditory stimuli in rat hippocampus

1 reference

12 December 2020

Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells

1 reference

12 December 2020

Muscarinic receptors--characterization, coupling and function

1 reference

12 December 2020

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

1 reference

12 December 2020

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology

1 reference

12 December 2020

Essential role of neocortical acetylcholine in spatial memory

1 reference

12 December 2020

Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats

1 reference

12 December 2020

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.

1 reference

12 December 2020

Noncompetitive agonism at nicotinic acetylcholine receptors; functional significance for CNS signal transduction

1 reference

12 December 2020

Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics.

1 reference

12 December 2020

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands

1 reference

12 December 2020

Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors

1 reference

12 December 2020

Nucleus basalis magnocellularis and medial septal area lesions differentially impair temporal memory.

1 reference

12 December 2020

m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC.

1 reference

12 December 2020

Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.

1 reference

12 December 2020

Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine.

1 reference

12 December 2020

Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine

1 reference

12 December 2020

Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.

1 reference

12 December 2020

In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia

1 reference

12 December 2020

Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients

1 reference

12 December 2020

Removal of the hippocampus and transection of the fornix produce comparable deficits on delayed non-matching to position by rats.

1 reference

12 December 2020

Differential Competition with Cytotoxic Agents: An Approach to Selectivity in Cancer Chemotherapy

1 reference

12 December 2020

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

1 reference

12 December 2020

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

1 reference

12 December 2020

(+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors

1 reference

12 December 2020

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

12 December 2020

The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.

1 reference

12 December 2020

Increased hippocampal acetylcholine release during a working memory task.

1 reference

12 December 2020

The effects of physostigmine and scopolamine on recognition memory in monkeys.

1 reference

12 December 2020

Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes

1 reference

12 December 2020

Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment

1 reference

12 December 2020

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

1 reference

12 December 2020

Memory and the septo-hippocampal cholinergic system in the rat.

1 reference

12 December 2020

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

1 reference

12 December 2020

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

1 reference

12 December 2020

Deficits in passive-avoidance learning following atropine in the developing rat

1 reference

12 December 2020

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

12 December 2020

Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine

1 reference

12 December 2020

Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia

1 reference

12 December 2020

Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine

1 reference

12 December 2020

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

12 December 2020

Prevalence of smoking among psychiatric outpatients

1 reference

12 December 2020

Distributions of nicotinic acetylcholine receptor alpha7 and beta2 subunits on cultured hippocampal neurons.

1 reference

12 December 2020

Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia

1 reference

12 December 2020

Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).

1 reference

12 December 2020

Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes

1 reference

12 December 2020

Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers

1 reference

12 December 2020

10.1007/S00213-004-1794-X

Identifiers

DOI

1 reference

10 August 2017

1 reference